Endo debuts generic Thiola EC
Endo is introducing Tiopronin delayed-release tablets, a generic version of Travere Therapeutics' Thiola EC.
The medication is used in combination with high fluid intake, alkali (low acid) and dietary changes to help prevent the formation of one type (cystine) of kidney stones in certain adult and pediatric patients.
"We're proud to provide high-quality, affordable choices to healthcare providers and their appropriate patients," said Scott Sims, senior vice president and general manager at Endo Injectable Solutions & Generics. "The launch of tiopronin delayed-release tablets strengthens our generic product portfolio and underscores our reputation as a reliable supplier."
[Read more: Endo to distribute bivalirudin injection in ready-to-use vials]
The medication is used in combination with high fluid intake, alkali (low acid), and dietary changes to help prevent the formation of one type (cystine) of kidney stones in certain adult and pediatric patients.
Endo is offering copay assistance for those who meet eligibility requirements. To learn more about Endo's Patient Assistance Program, patients can call (833) 727-4357.
[Read more: Endo to distribute bivalirudin injection in ready-to-use vials]